Increased Bladder Cancer Risk with Actos
Diabetes Drug Linked to Bladder Cancer
The FDA reviewed an interim report of a 10-year study on a bladder cancer-Actos connection and found a suspected link between Actos and bladder cancer. Recently, the FDA reported that patients using Actos (Pioglitazone) for a year or longer have a substantially increased risk of bladder cancer. You should not take Actos if you are receiving treatment for bladder cancer.
Because of this increased risk, current and past users of Actos should be aware of the symptoms of bladder cancer and should tell their doctor right away if they have any of the following symptoms:
- Blood or a red color in urine
- An increased need to urinate
- Pain and burning while urinating
- Frequent urination
- Abdominal pain (infection)
- Lower back pain
Cancer of the bladder is the fourth most common cancer among men and the ninth most common cancer among women. The American Cancer Society’s estimates about 73,500 new cases of bladder cancer have been diagnosed, resulting in approximately 15,000 deaths this year in the U.S.
Bladder cancer is almost always curable if detected and treated early, with a 5-year survival rate of more than 90%. However, advanced disease is much more difficult to treat.
If you or a loved one suspects bladder cancer, contact your doctor immediately. If you have been injured, have been diagnosed with bladder cancer, or have lost a loved one as a result of taking Actos and would like to learn more about your legal rights, please contact us here or call (954) 509-1900. We offer free consultations and charge you only if we win your case.